戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 used oral contraceptives, a diaphragm, or an intrauterine device.
2 l ring, new formulations of pills, and a new intrauterine device.
3 eversible contraception (LARC), specifically intrauterine devices and implants, offers an unprecedent
4 sing other contraceptive methods, except for intrauterine devices and permanent methods, had 3.1-4.1
5 g all other contraceptive methods except for intrauterine devices and permanent methods.
6 t brachial plexus injury, dislodgement of an intrauterine device, and vaginal granulation tissue.
7                             Barrier methods, intrauterine devices, and progestins can be used.
8 ligation, rhythm method, diaphragm, condoms, intrauterine device, foam, spousal vasectomy) and infert
9                                          The intrauterine device is not a risk factor for this condit
10 ntibiotic prophylaxis before insertion of an intrauterine device (IUD) remains uncertain.
11                  LARC methods, which include intrauterine devices (IUDs) and subdermal hormonal impla
12 ing reversible contraceptive methods include intrauterine devices (IUDs) and subdermal implants and s
13                   Contraceptive implants and intrauterine devices (IUDs) are long-acting reversible c
14             This review discusses the use of intrauterine devices (IUDs) in United States teens as a
15 out upper-genital-tract infection related to intrauterine devices (IUDs) limits their wider use.
16 ng on providing counselling and insertion of intrauterine devices (IUDs) or progestin implants and 20
17                                              Intrauterine devices (IUDs) provide highly effective, re
18                          Previous studies of intrauterine devices (IUDs), many of which are no longer
19 ure of long-acting reversible contraception (intrauterine devices [IUDs] and implants) with other com
20 (DMPA; n = 32), the levonorgestrel-releasing intrauterine device (LNG-IUD; n = 27), oral contraceptiv
21 s and women enrolled in CHOICE, 72% chose an intrauterine device or implant (LARC methods); the remai
22 distinguish those reporting use of (1) LARC (intrauterine device or implant), (2) oral contraceptives
23 ould select birth control pills; condoms; an intrauterine device or implant; injection, patch, or rin
24 hildren; HR = 0.42, 95% CI: 0.19, 0.90), and intrauterine device use (HR = 0.59, 95% CI: 0.41, 0.86)
25  with decreased ovarian cancer risk, whereas intrauterine device use (RR = 1.76, 95% CI: 1.08, 2.85)
26                 Furthermore, tubal ligation, intrauterine device use, and infertility were associated
27 titution, workplace, hormonal contraception, intrauterine-device use, alcohol consumption, syphilis,

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。